Abstract:BackgroundMELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) is a common subtype of mitochondrial encephalomyopathy. However, few studies have explored the relationship between biochemical markers and prognosis. This study aimed to explore the relationship between clinical and biochemical markers and prognosis of patients with MELAS.MethodsThis was a retrospective single-center study. A total of 39 MELAS patients were followed for an average of 7.3 ± 4.7 (range 1–21 years). All patients underwent detailed demographic registration, neurological examinations, biochemical and mitochondrial DNA analyses, muscle biopsy. Throughout the follow-up period, the modified Rankin Scale (mRS) scores, recurrent strokes rates, and mortality were tracked.ResultsAll patients initially presented with stroke-like episodes. Of the 39 subjects who were followed, 8 died, primarily due to acute stroke-like episodes and status epilepticus. Univariate analysis showed a higher risk of mortality in patients with severe lactate elevation compared to those with normal and mildly elevated levels (OR = 5.714, 95% CI 1.086–30.071, p = 0.040). While the absence of anemia was associated with a lower risk of death compared to those with anemia (OR = 0.175, 95% CI 0.033–0.921, p = 0.040). In multivariate analysis, severe lactate elevation (OR = 7.279, 95% CI 1.102–48.086, p = 0.039) and anemia (OR = 0.137, 95% CI 0.021–0.908, p = 0.039) were identified as independent predictors of mortality. MRS scores were categorized as follows: 41% of patients scored 0 to 2, 38.5% scored 3 to 5, and 20.5% had a score of 6 or had died. There was a positive correlation between lactic acid levels and MRS scores (r = 0.460, p = 0.003). In contrast, hemoglobin levels were negatively correlated with MRS scores (r = −0.375, p = 0.015). Furthermore, a positive correlation was observed between MRS scores and the frequency of stroke-like episodes (r = 0.280, p = 0.042).ConclusionOur study found that the majority of patients with MELAS had poor clinical outcomes. Anemia and significantly increased lactate levels were identified as indicators of poor prognosis in MELAS. Early intervention may lead to improvements in clinical outcomes.

Altered spontaneous brain activity at attack and remission stages in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): Beyond stroke-like lesions

Metabolic abnormality in acute stroke-like lesion and its relationship with focal cerebral blood flow in patients with MELAS: Evidence from proton MR spectroscopy and arterial spin labeling

Dynamic Evolution of Brain Magnetic Resonance Imaging Findings in Patients with Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome

An analysis of the clinical and imaging features of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)

Topological Reorganization of Brain Functional Networks in Patients with Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke Like Episodes

Altered Dynamic Functional Connectivity in Patients with Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke‐Like Episodes (MELAS) at Acute and Chronic Stages: Shared and Specific Brain Connectivity Abnormalities

Evaluation of Vascular Autoregulation in Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis,and Stroke-Like Episodes Patients

MR Evaluation of Cerebral Oxygen Metabolism and Blood Flow in Stroke-Like Episodes of MELAS

Neuroimaging Features in Mitochondrial Encephalomyopathies with Lactic Acidosis and Stroke-Like Episodes in 22 Patients

Conventional and Diffusional Magnetic Resonance Imaging Features of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes in Chinese Patients: A Study of 40 Cases

Application of MRI/MRS in differential diagnosis of MELAS syndrome and stroke

Epileptic Seizures and Electroencephalographic Findings in Patients with Mitochondrial Myopathy Encephalopathy, Lactic Acidosis and Stroke-Like Episodes

Reversible brain dysfunction in MELAS: MEG, and 1H MRS analysis

MRI Features of Stroke-Like Episodes in Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes

Quantitative Measurement of Cerebral Oxygen Extraction Fraction Using MRI in Patients with MELAS

Reversible Dilation of Cerebral Macrovascular Changes in MELAS Episodes

Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy

The appearance of ADCs in the non-affected areas of the patients with MELAS

Cerebral blood flow, vascular response and metabolism in patients with MELAS syndrome--xenon CT and PET study

Long-term prognostic factors and outcomes in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes: a clinical and biochemical marker analysis

A patient with MELAS syndrome combined with autoimmune abnormalities: a case report